CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on July 8, 2020
July 8, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance; Office of Life Sciences
Attn: Mr. Gabor
100 F. Street, N.E.
Washington, D.C. 20549
Re: Know Labs, Inc. (the “Company”)
Registration Statement on Form S-1
File No. 333-239563
Ladies and Gentlemen:
The Company hereby withdraws its acceleration request submitted by letter dated July 6, 2020 with respect to the above-referenced Registration Statement on Form S-1. The Company is requesting acceleration of effectiveness for the above-referenced Registration Statement on Form S-1 by separate letter of even date.
Thank you for your assistance. If you should have any questions, please contact feel free to contact me.
Very truly yours,
KNOW LABS, INC.
By: /s/ Ronald P. Erickson
Name: Ronald P. Erickson
Title: Chairman of the Board and
Interim Chief Financial Officer
cc: Horwitz + Armstrong, A Prof. Law Corp.
Jessica M. Lockett, Esq.